IP, Pharma Groups Call For Patent Eligibility Law Overhaul
Citing the confusion caused by recent court rulings on patent-eligibility, major intellectual property and pharmaceutical industry groups have suggested to the U.S. Patent and Trademark Office that the time has come...To view the full article, register now.
Already a subscriber? Click here to view full article